"MD Anderson provides medical oncology, radiation oncology and surgical oncology services along with a range of supportive programs. While we treat all types of cancers in The Woodlands, the faculty here has particular expertise in the diagnosis, treatment and management of the following cancers: Breast Colorectal Dermatology and skin Endocrine Genitourinary Gynecologic Head and neck Neurologic Thoracic The Woodlands also offers the following treatment support services: Cancer pain management Clinical nutrition Diagnostic imaging Diagnostic laboratory center for blood testing Pharmacy Physical therapy and occupational therapy Social work counseling Support groups In addition MD Anderson The Woodlands has a coffee bar offering sandwiches"

During the past decade, MD Anderson in The Woodlands conducted 57 clinical trials. In the 10-year time frame, 57 clinical trials started and 17 clinical trials were completed, i.e. on average, 29.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 17 clinical trials were completed. i.e. 141.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MD Anderson in The Woodlands" #1 sponsor was "M.D. Anderson Cancer Center" with 29 trials, followed by "National Cancer Institute (NCI)" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "NRG Oncology" with 8 trials sponsored and "SWOG Cancer Research Network" with 8 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MD Anderson in The Woodlands" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "MD Anderson in The Woodlands" are "Invasive Breast Carcinoma" (7 trials), "Primary Peritoneal Serous Adenocarcinoma" (6 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (5 trials), "Fallopian Tube Serous Adenocarcinoma" (5 trials) and "Ovarian Clear Cell Adenocarcinoma" (5 trials). Many other conditions were trialed in "MD Anderson in The Woodlands" in a lesser frequency.

Most popular intervention types in "MD Anderson in The Woodlands" are "Other" (59 trials), "Drug" (54 trials), "Radiation" (28 trials), "Procedure" (25 trials) and "Biological" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (33 trials), "Quality-of-Life Assessment" (23 trials), "Questionnaire Administration" (17 trials), "Carboplatin" (13 trials) and "Paclitaxel" (13 trials). Other intervention names were less common.

The vast majority of trials in "MD Anderson in The Woodlands" are 47 trials for "All" genders, 26 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "MD Anderson in The Woodlands". undefined are not yet recruiting, 28 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in MD Anderson in The Woodlands, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in MD Anderson in The Woodlands, 5 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".